Bod Australia Ltd (AU:BOD) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bod Science Limited has announced a deferral of its Annual General Meeting and financial reporting obligations due to its external administration status. The company, which focuses on cannabis-based drug development, will rely on regulatory relief to delay these requirements for up to 24 months. Investors are advised to monitor the situation as BOD navigates this period of financial restructuring.
For further insights into AU:BOD stock, check out TipRanks’ Stock Analysis page.